Citation APA
Olivotto, I., Oreziak, A., Barriales-Villa, R., Abraham, T. P., Masri, A., Garcia-Pavia, P., Saberi, S., Lakdawala, N. N., Wheeler, M. M., Owens, A., Kubanek, M., Wojakowski, W., Jensen, M. K., Gimeno-Blanes, J., Afshar, K., Myers, J., Hegde, S. S., Solomon, S. D., Sehnert, A. A., Zhang, D., Li, W., Bhattacharya, M., Edelberg, J. J., Waldman, C. B., Lester, S. J., Wang, A., Ho, C. Y., Jacoby, D., & Bondue, A. (2020). Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 396(10253), 759-769. doi:10.1016/S0140-6736(20)31792-X
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/378797